Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Ferring Pharmaceuticals
Ferring Pharmaceuticals
A first look at Ferring and Posterity’s male fertility mission
Medical Marketing and Media
Thu, 06/20/24 - 05:54 pm
Fertility
Ferring Pharmaceuticals
Ferring’s microbiome and gene therapy firsts take the company beyond reproductive health
Pharma Voice
Thu, 02/22/24 - 11:45 am
Ferring Pharmaceuticals
gene therapy
microbiome
bladder cancer
C. difficile
Royalty Pharma to Pay Potential $500M for Royalties on Ferring’s Gene Therapy
BioSpace
Thu, 08/24/23 - 08:34 pm
Ferring Pharmaceuticals
Royalty Pharma
gene therapy
bladder cancer
Ferring, with manufacturing update, takes a step towards first gene therapy sales
BioPharma Dive
Wed, 06/14/23 - 10:07 am
Ferring Pharmaceuticals
FDA
bladder cancer
gene therapy
Adstiladrin
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
CP Wire
Mon, 04/3/23 - 03:35 pm
CVS Health
Signify Health
M&A
Ferring Pharmaceuticals
Pfizer
Bristol Myers Squibb
Eli Lilly
Novo Nordisk
Boehringer Ingelheim
Jardiance
Ozempic
drug pricing
Eliquis
CMS
Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more
Mon, 04/3/23 - 03:33 pm
CVS Health
Signify Health
M&A
Ferring Pharmaceuticals
Pfizer
Bristol Myers Squibb
Eli Lilly
Novo Nordisk
Boehringer Ingelheim
Jardiance
Ozempic
drug pricing
Eliquis
CMS
Go or no go? Seagen's Padcev eyes FDA approval
EP Vantage
Mon, 04/3/23 - 09:41 am
FDA
AbbVie
Alvotech
Ascendis Pharma
Astellas
AstraZeneca
Biogen
Daiichi Sankyo
Eli Lilly
Ferring Pharmaceuticals
Hugel
Innoviva
Ionis Pharmaceuticals
Lundbeck
Merck
Novo Nordisk
Otsuka
Pfizer
Roche Seagen
Seres Therapeutics
Takeda
UCB
Vertex Pharmaceuticals
Ferring shuts down U.S.-based research institute after more than 25 years, cutting nearly 90 employees
Fierce Biotech
Tue, 03/28/23 - 11:28 am
Ferring Pharmaceuticals
San Diego
California
layoffs
A renewed push into early bladder cancer
EP Vantage
Thu, 02/2/23 - 10:24 am
Ferring Pharmaceuticals
Adstiladrin
FDA
gene therapy
bladder cancer
Ferring wins FDA approval for bladder cancer gene therapy
BioPharma Dive
Tue, 12/20/22 - 11:07 am
Ferring Pharmaceuticals
bladder cancer
gene therapy
FDA
Adstiladrin
This Week at FDA: FDA approves first FMT product, upcoming mpox guidance, and more
RAPS.org
Sun, 12/4/22 - 01:29 pm
FDA
regulatory
mpox
Ferring Pharmaceuticals
microbiome
COVID-19
Eli Lilly
FDA approves first fecal microbiome drug, setting stage for others
Stat
Thu, 12/1/22 - 10:41 am
Ferring Pharmaceuticals
Rebyota
FDA
C. difficile
fecal microbiome
microbiome
FDA panel recommends Ferring's fecal transplant therapy
NASDAQ
Fri, 09/23/22 - 10:47 am
Ferring Pharmaceuticals
fecal transplants
C. difficile
FDA
Go or no go? Bristol’s Tyk2 test
EP Vantage
Wed, 08/31/22 - 10:15 am
FDA
Bristol Myers Squibb
deucravacitinib
Amylyx Pharmaceuticals
ALS
AMX0035
Ferring Pharmaceuticals
microbiome
RBX2660
Revance Therapeutics
Bluebird Bio
Spectrum Pharmaceuticals
JNJ
Oncopeptides
FDA's vaccine adcomm to review first fecal transplant to treat C. difficile infections
Endpoints
Mon, 08/8/22 - 11:39 pm
FDA
Ferring Pharmaceuticals
Rebiotix
RBX2660
C. difficile
The year the regulators meet the microbiome
EP Vantage
Thu, 03/24/22 - 10:47 am
microbiome
Seres Therapeutics
Ferring Pharmaceuticals
FDA
C. difficile
Ferring’s gut microbiome drug clears phase 3 trial in C. diff
Pharmaforum
Thu, 05/7/20 - 10:41 am
Ferring Pharmaceuticals
clinical trials
microbiome
C. difficile
RBX2660
FerGene’s Bladder Cancer Phase III Trial Hits Its Mark
BioSpace
Fri, 12/6/19 - 10:09 am
FerGene
gene therapy
bladder cancer
NMIBC
Ferring Pharmaceuticals
Blackstone Life Sciences
clinical trials